O'Hara J - Search Results

1

Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs.

Chowdary P, Ofori-Asenso R, Nissen F, Grazzi EF, Aizenas M, Moreno K, Burke T, Nolan B, O'Hara J, Khair K. Chowdary P, et al. TH Open. 2024 Apr 15;8(2):e181-e193. doi: 10.1055/s-0044-1785524. eCollection 2024 Apr. TH Open. 2024. PMID: 38628421 Free PMC article.

2

The cost of severe haemophilia in Europe: the CHESS study.

O'Hara J, Hughes D, Camp C, Burke T, Carroll L, Diego DG. O'Hara J, et al. Orphanet J Rare Dis. 2017 May 31;12(1):106. doi: 10.1186/s13023-017-0660-y. Orphanet J Rare Dis. 2017. PMID: 28569181 Free PMC article.

3

Inhibitor clinical burden of disease: a comparative analysis of the CHESS data.

Oladapo AO, Lu M, Walsh S, O'Hara J, Kauf TL. Oladapo AO, et al. Orphanet J Rare Dis. 2018 Nov 9;13(1):198. doi: 10.1186/s13023-018-0929-9. Orphanet J Rare Dis. 2018. PMID: 30413215 Free PMC article.

4

The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting Partnership.

Shapiro S, Stephensen D, Camp C, Carroll L, Collins P, Elston D, Gallagher P, Khair K, McKeown W, O'Hara J, Stanworth S, Waterman A, Woollard L, Upadhyaya S, Laffan M. Shapiro S, et al. Br J Haematol. 2019 Aug;186(4):e98-e100. doi: 10.1111/bjh.15928. Epub 2019 Apr 23. Br J Haematol. 2019. PMID: 31016727 Free article. No abstract available.

5

Understanding minimum and ideal factor levels for participation in physical activities by people with haemophilia: An expert elicitation exercise.

Martin AP, Burke T, Asghar S, Noone D, Pedra G, O'Hara J. Martin AP, et al. Haemophilia. 2020 Jul;26(4):711-717. doi: 10.1111/hae.13985. Epub 2020 Apr 8. Haemophilia. 2020. PMID: 32268007

6

Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis.

O'Hara J, Hirst C, Cabre Marquez JF, Burke T. O'Hara J, et al. Orphanet J Rare Dis. 2021 Jan 15;16(1):33. doi: 10.1186/s13023-021-01676-w. Orphanet J Rare Dis. 2021. PMID: 33451335 Free PMC article.

7

Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model.

Li N, Sawyer EK, Maruszczyk K, Guzauskas G, Slomka MT, Burke T, Martin AP, O'Hara J, Stevenson M, Recht M. Li N, et al. J Med Econ. 2021 Jan-Dec;24(1):363-372. doi: 10.1080/13696998.2021.1891088. J Med Econ. 2021. PMID: 33591884 Free article.

8

Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys.

Burke T, Asghar S, O'Hara J, Sawyer EK, Li N. Burke T, et al. Orphanet J Rare Dis. 2021 Mar 20;16(1):143. doi: 10.1186/s13023-021-01774-9. Orphanet J Rare Dis. 2021. PMID: 33743752 Free PMC article.

9

Clinical attributes and treatment characteristics are associated with work productivity and activity impairment in people with severe haemophilia A.

O'Hara J, Noone D, Jain M, Pedra G, Landis S, Hawes C, Burke T, Camp C. O'Hara J, et al. Haemophilia. 2021 Nov;27(6):938-946. doi: 10.1111/hae.14302. Epub 2021 Jul 17. Haemophilia. 2021. PMID: 34273215

10

Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.

Burke T, Asghar S, O'Hara J, Chuang M, Sawyer EK, Li N. Burke T, et al. Orphanet J Rare Dis. 2021 Dec 20;16(1):521. doi: 10.1186/s13023-021-02152-1. Orphanet J Rare Dis. 2021. PMID: 34930388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

724 results

Search Page

Filters